Stock News

Equifax: A Strong Buy with a One-Year Price Target of $360 Per Share Overview In light of Equifax’s impressive performance in Q2, I reiterate a ‘Strong Buy’ rating for the company with a one-year price target of $360 per share. Equifax has shown robust growth in its non-mortgage businesses, offsetting the decline in mortgage revenue….

The law firm of Kessler Topaz Meltzer & Check, LLP has recently brought to light a securities class action lawsuit against Extreme Networks, Inc. If you are one of those unfortunate investors who purchased or acquired Extreme common stock between July 27, 2022, and January 30, 2024, then this news is definitely for you. The…

Makes Any Licensing Agreement Fully Contingent on DIRECTV Waiving Future Challenge of Antitrust Actions Seeks to Avoid Future Considerations by U.S. District Judge Margaret Garnett or Southern District of New York by Limiting Legal Venues Available to DIRECTV Consumers at Risk for Paying for Disney Content Twice and Channels They Do Not Want, While ABC-Owned…

Levi & Korsinsky Investigates Biomea Fusion, Inc. – Potential Violations of Securities Laws Investigation Announcement New York, NY / ACCESSWIRE / September 1, 2024 / Levi & Korsinsky has initiated an investigation into Biomea Fusion, Inc. (NASDAQ:BMEA) for potential breaches of federal securities laws. The investigation stems from a recent press release issued by Biomea…

Welcome to the Wild and Wacky World of Cardiology! The GUARD-AF Trial: A Comedy of Errors or a Triumph of Science? Picture this: a group of researchers at the European Society of Cardiology (ESC) Congress 2024, gathered to present the results of the GUARD-AF trial. Armed with iRhythm’s Zio ® patch-based long-term continuous monitoring (LTCM),…

Unleashing the Power of Emotion: A Heartfelt and Insightful Journey A Journey of Self-Discovery Emotions are a powerful force that shapes our experiences and perceptions of the world around us. They have the ability to influence our thoughts, actions, and relationships in profound ways. When we learn to tap into and unleash the power of…

Welcome to the Wild World of Securities Lawsuits! What’s the Buzz? So, there’s been some drama going on in the world of securities lately. Pomerantz LLP just dropped a bomb of an announcement – they’ve filed a class action lawsuit against Lifecore Biomedical, Inc. and some of their bigwig executives. The lawsuit, filed in the…

Pomerantz LLP Announces Class Action Lawsuit Against Ardelyx, Inc. Class Action Lawsuit Details Pomerantz LLP has announced that a class action lawsuit has been filed against Ardelyx, Inc. (“Ardelyx” or the “Company”) (NASDAQ:ARDX) and certain officers. The class action, filed in the United States District Court for the District of Massachusetts, is on behalf of…